🇺🇸 FDA

Company profile · Sponsor

Hospital

Hospital Authority, Hong Kong

C68FF49 · NMPA pharma CN
Pipeline
24
Drugs
0
Patents
0

Quick answer

Hospital (C68FF49) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C68FF49
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (24)

Search pipeline →

  1. 1 apical pleurectomy

    Hospital

    Pneumothorax

    phase 3 other active

    1 trial

  2. AST-120and pentoxyphylline (PTX)

    Hospital

    Acute Kidney Injury

    phase 3 small molecule active

    1 trial

  3. Autologous Peripheral Blood Stem Cell injection

    Hospital

    Acute Myocardial Infarction

    phase 3 mab active

    1 trial

  4. Bacillus Calmette Guerin and interferon alpha

    Hospital

    Carcinoma of Urinary Bladder, Superficial

    phase 3 small molecule completed

    1 trial

  5. Barley beta-glucan(3.0g)

    Hospital

    Overweight; Hyperlipidemia

    phase 3 other completed

    1 trial

  6. Bevacizumab

    Hospital

    Proliferative Diabetic Retinopathy

    phase 3 small molecule completed

    1 trial

  7. Bortezomib

    Hospital

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  8. Botulinum toxin type A

    Hospital

    Obesity

    phase 3 small molecule active

    1 trial

  9. Cannabidiol Oil

    Hospital

    Dementia, Vascular

    phase 3 small molecule active

    1 trial

  10. Capecitabine plus temozolamide

    Hospital

    Neuroendocrine Neoplasia's (NENs)

    phase 3 small molecule active

    1 trial

  11. Champix

    Hospital

    Tobacco Use Disorder

    phase 3 small molecule completed

    1 trial

  12. Control

    Hospital

    Hallucinations, Verbal Auditory

    phase 3 small molecule active

    1 trial

  13. Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF

    Hospital

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  14. Dexmedetomidine Hcl 100 Mcg/mL Inj

    Hospital

    Congenital Heart Disease in Children

    phase 3 small molecule completed

    1 trial

  15. Dienogest

    Hospital

    Endometriosis

    phase 3 small molecule active

    1 trial

  16. Doxycycline

    Hospital

    Tuberculosis

    phase 3 small molecule active

    1 trial

  17. Empagliflozin 10 MG

    Hospital

    Diabetic Nephropathies

    phase 3 small molecule terminated

    1 trial

  18. Eriobotyra Japonica Lindley Extract

    Hospital

    Cognitive Function

    phase 3 other completed

    1 trial

  19. Finished Herbal Product such as Suan Tsao Jen Tang, Jia-Wey Shiau-Yau San

    Hospital

    Menopausal Women

    phase 3 small molecule active

    1 trial

  20. Flublok Quadrivalent vaccine

    Hospital

    Influenza Vaccination

    phase 3 mab completed

    1 trial

  21. Formosa 1-Breath Free (NRICM101)

    Hospital

    Influenza Viral Infections

    phase 3 small molecule active

    1 trial

  22. Fractional CO2 Laser

    Hospital

    Treatments of Striae Gravidarum

    phase 3 other active

    1 trial

  23. GCSF

    Hospital

    End Stage Liver Disease

    phase 3 small molecule active

    1 trial

  24. Intravenous methylene blue administration

    Hospital

    Severe Sepsis

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Hospital?

Hospital (C68FF49) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Hospital sponsor?

We track 24 ClinicalTrials.gov-linked programs for Hospital, including 1 apical pleurectomy and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Hospital company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.